{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:24:25Z","timestamp":1775467465478,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1000400"],"award-info":[{"award-number":["2016YFC1000400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["2019YFS0401"],"award-info":[{"award-number":["2019YFS0401"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Gestational diabetes mellitus (GDM) has a complicated pathophysiology originating from interactions between susceptibility genes and adverse environmental factors. The transcription factor GLI-similar 3 (\n                      <jats:italic>GLIS3<\/jats:italic>\n                      ) rs7034200C\/A and adrenergic receptor beta 3 (\n                      <jats:italic>ADRB3<\/jats:italic>\n                      ) rs4994T\/C (Trp64Arg) polymorphisms are closely related to glucolipid metabolism, insulin resistance, obesity, and increased risk of type 2 diabetes. However, the association of these two polymorphisms with GDM in Chinese remains unknown. Therefore, this study explored the relationship between these two genetic variants and the risk of GDM, and assessed the effects of genotypes on glucolipid metabolism, oxidative stress, and clinical indicators.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case-control study included 701 women with GDM and 1034 controls. The rs7034200C\/A and rs4994T\/C variants were genotyped using polymerase chain reaction-restriction fragment length polymorphism method. Clinical and biochemical parameters were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>GLIS3<\/jats:italic>\n                      rs7034200C\/A polymorphism was associated with an elevated risk of GDM according to the genotype, allele, dominant, and recessive genetic models (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). After correcting for maternal age, pre-pregnancy BMI, and gestational age at sampling, the dominant and recessive models retained statistical significance in the binary logistic regression models (odds ratio [OR]\u2009=\u20091.268 and 1.334, 95% confidence interval [CI]: 1.017\u20131.580 and 1.020\u20131.745, respectively;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) ; the AA genotype showed a higher risk for GDM, with the CC genotype as the reference, in a multinomial logistic regression model (OR\u2009=\u20091.519, 95% CI: 1.120\u20132.061;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007). No significant discrepancies were observed in the\n                      <jats:italic>ADRB3<\/jats:italic>\n                      rs4994T\/C polymorphism based on different genetic models (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). However, the AA\/TT combined genotype of the\n                      <jats:italic>GLIS3<\/jats:italic>\n                      rs7034200C\/A and\n                      <jats:italic>ADRB3<\/jats:italic>\n                      rs4994T\/C polymorphisms was associated with an elevated risk of GDM, with the CC\/TT combined genotype as a reference (OR\u2009=\u20091.708, 95% CI: 1.191\u20132.450;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004). Furthermore, the\n                      <jats:italic>GLIS3<\/jats:italic>\n                      rs7034200C\/A variant significantly affected oxidative stress, insulin resistance, and glucolipid metabolism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The A allele and AA genotype of the\n                      <jats:italic>GLIS3<\/jats:italic>\n                      rs7034200C\/A polymorphism, along with the AA\/TT combined genotype of the\n                      <jats:italic>GLIS3<\/jats:italic>\n                      rs7034200C\/A and\n                      <jats:italic>ADRB3<\/jats:italic>\n                      rs4994T\/C variants, are genetic risk factors for GDM in Chinese women.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-025-08436-9","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:54:16Z","timestamp":1763740456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GLIS3 rs7034200 and ADRB3 rs4994 genetic variants associated with an increased risk of gestational diabetes mellitus in Chinese women: a case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Liping","family":"Shui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guolin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"Suppl 1","key":"8436_CR1","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice C. 2","year":"2024","unstructured":"American Diabetes Association Professional Practice C. 2. Diagnosis and classification of diabetes: standards of care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u201342.","journal-title":"Diabetes Care"},{"issue":"11","key":"8436_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.tem.2018.09.004","volume":"29","author":"EC Johns","year":"2018","unstructured":"Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018;29(11):743\u201354.","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"8436_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11892-017-0922-z","volume":"17","author":"FM Brown","year":"2017","unstructured":"Brown FM, Wyckoff J. Application of One-Step IADPSG versus Two-Step diagnostic criteria for gestational diabetes in the real world: impact on health Services, clinical Care, and outcomes. Curr Diab Rep. 2017;17(10):85.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"8436_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/jdi.12854","volume":"10","author":"C Gao","year":"2019","unstructured":"Gao C, Sun X, Lu L, Liu F, Yuan J. Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis. J Diabetes Investig. 2019;10(1):154\u201362.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"8436_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1210\/endrev\/bnac003","volume":"43","author":"A Sweeting","year":"2022","unstructured":"Sweeting A, Wong J, Murphy HR, Ross GP. A clinical update on gestational diabetes mellitus. Endocr Rev. 2022;43(5):763\u201393.","journal-title":"Endocr Rev"},{"issue":"1","key":"8436_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91258-8","volume":"15","author":"S Zeng","year":"2025","unstructured":"Zeng S, Liu Q, Wu Y, Bai H, Fan P, Liu X. Reduced low-density lipoprotein cholesterol levels are associated with increased risk of gestational diabetes mellitus in Chinese women. Sci Rep. 2025;15(1):6435.","journal-title":"Sci Rep"},{"issue":"1","key":"8436_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jdi.14119","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhou Z, Li H. The role of lipid dysregulation in gestational diabetes mellitus: early prediction and postpartum prognosis. J Diabetes Investig. 2024;15(1):15\u201325.","journal-title":"J Diabetes Investig"},{"key":"8436_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3483427","volume":"2020","author":"M Zhou","year":"2020","unstructured":"Zhou M, Liu XH, Liu QQ, Chen M, Bai H, Guan LB, et al. Lactonase activity, status, and genetic variations of paraoxonase 1 in women with gestational diabetes mellitus. J Diabetes Res. 2020;2020:3483427.","journal-title":"J Diabetes Res"},{"key":"8436_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.602477","volume":"11","author":"MG Dalfra","year":"2020","unstructured":"Dalfra MG, Burlina S, Del Vescovo GG, Lapolla A. Genetics and epigenetics: new insight on gestational diabetes mellitus. Front Endocrinol (Lausanne). 2020;11:602477.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"8436_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/humupd\/dmaa011","volume":"26","author":"JK Bosdou","year":"2020","unstructured":"Bosdou JK, Anagnostis P, Goulis DG, Lainas GT, Tarlatzis BC, Grimbizis GF, et al. Risk of gestational diabetes mellitus in women achieving singleton pregnancy spontaneously or after ART: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(4):514\u201344.","journal-title":"Hum Reprod Update"},{"key":"8436_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107632","volume":"215","author":"DW Scoville","year":"2020","unstructured":"Scoville DW, Kang HS, Jetten AM. Transcription factor GLIS3: critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes. Pharmacol Ther. 2020;215:107632.","journal-title":"Pharmacol Ther"},{"issue":"19","key":"8436_CR12","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1007\/s00018-018-2841-9","volume":"75","author":"AM Jetten","year":"2018","unstructured":"Jetten AM. GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases. Cell Mol Life Sci. 2018;75(19):3473\u201394.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"8436_CR13","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1530\/JME-16-0232","volume":"58","author":"X Wen","year":"2017","unstructured":"Wen X, Yang Y. Emerging roles of GLIS3 in neonatal diabetes, type 1 and type 2 diabetes. J Mol Endocrinol. 2017;58(2):R73\u201385.","journal-title":"J Mol Endocrinol"},{"key":"8436_CR14","doi-asserted-by":"publisher","first-page":"1036088","DOI":"10.3389\/fendo.2022.1036088","volume":"13","author":"A Ramos-Levi","year":"2022","unstructured":"Ramos-Levi A, Barabash A, Valerio J, Garcia de la Torre N, Mendizabal L, Zulueta M, et al. Genetic variants for prediction of gestational diabetes mellitus and modulation of susceptibility by a nutritional intervention based on a mediterranean diet. Front Endocrinol (Lausanne). 2022;13:1036088.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"8436_CR15","doi-asserted-by":"publisher","first-page":"e24710","DOI":"10.1371\/journal.pone.0024710","volume":"6","author":"SD Rees","year":"2011","unstructured":"Rees SD, Hydrie MZ, O\u2019Hare JP, Kumar S, Shera AS, Basit A, et al. Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South asians: ADCY5 and GLIS3 variants May predispose to type 2 diabetes. PLoS ONE. 2011;6(9):e24710.","journal-title":"PLoS ONE"},{"issue":"6","key":"8436_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021464","volume":"6","author":"C Liu","year":"2011","unstructured":"Liu C, Li H, Qi L, Loos RJ, Qi Q, Lu L, et al. Variants in GLIS3 and CRY2 are associated with type 2 diabetes and impaired fasting glucose in Chinese Hans. PLoS ONE. 2011;6(6):e21464.","journal-title":"PLoS ONE"},{"issue":"11","key":"8436_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015542","volume":"5","author":"C Hu","year":"2010","unstructured":"Hu C, Zhang R, Wang C, Wang J, Ma X, Hou X, et al. Variants from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1, SLC30A8 and IGF1 are associated with glucose metabolism in the Chinese. PLoS One. 2010;5(11):e15542.","journal-title":"PLoS One"},{"issue":"2","key":"8436_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/ng.520","volume":"42","author":"J Dupuis","year":"2010","unstructured":"Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105\u201316.","journal-title":"Nat Genet"},{"issue":"1","key":"8436_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/21623945.2020.1722549","volume":"9","author":"C Xie","year":"2020","unstructured":"Xie C, Hua W, Zhao Y, Rui J, Feng J, Chen Y, et al. The ADRB3 rs4994 polymorphism increases risk of childhood and adolescent overweight\/obesity for East Asia\u2019s population: an evidence-based meta-analysis. Adipocyte. 2020;9(1):77\u201386.","journal-title":"Adipocyte"},{"key":"8436_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.diabres.2017.03.034","volume":"129","author":"JA Ryuk","year":"2017","unstructured":"Ryuk JA, Zhang X, Ko BS, Daily JW, Park S. Association of beta3-adrenergic receptor rs4994 polymorphisms with the risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2017;129:86\u201396.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"8436_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1159\/000495116","volume":"11","author":"WY Cao","year":"2018","unstructured":"Cao WY, Liu Z, Guo F, Yu J, Li H, Yin X. Adipocyte ADRB3 Down-Regulated in Chinese overweight individuals adipocyte ADRB3 in overweight. Obes Facts. 2018;11(6):524\u201333.","journal-title":"Obes Facts"},{"key":"8436_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0395-2","volume":"13","author":"A Kurylowicz","year":"2015","unstructured":"Kurylowicz A, Jonas M, Lisik W, Jonas M, Wicik ZA, Wierzbicki Z, et al. Obesity is associated with a decrease in expression but not with the hypermethylation of thermogenesis-related genes in adipose tissues. J Transl Med. 2015;13:31.","journal-title":"J Transl Med"},{"issue":"6","key":"8436_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJM199508103330603","volume":"333","author":"J Walston","year":"1995","unstructured":"Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med. 1995;333(6):343\u20137.","journal-title":"N Engl J Med"},{"issue":"8","key":"8436_CR24","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s00125-018-4637-8","volume":"61","author":"M Ding","year":"2018","unstructured":"Ding M, Chavarro J, Olsen S, Lin Y, Ley SH, Bao W, et al. Genetic variants of gestational diabetes mellitus: a study of 112 SNPs among 8722 women in two independent populations. Diabetologia. 2018;61(8):1758\u201368.","journal-title":"Diabetologia"},{"issue":"3","key":"8436_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"P Consensus","year":"2010","unstructured":"International Association of D, Pregnancy Study Groups, Consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676\u201382.","journal-title":"Diabetes Care"},{"issue":"2","key":"8436_CR26","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","volume":"131","author":"ACOG Practice Bulletin No","year":"2018","unstructured":"ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49\u201364.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"8436_CR27","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0369","volume":"12","author":"C Jiang","year":"2023","unstructured":"Jiang C, Zhou M, Bai H, Chen M, Yang C, Hu K, et al. Myeloperoxidase G-463A and CYBA C242T genetic variants in gestational diabetes mellitus. Endocr Connect. 2023;12(3):e220369.","journal-title":"Endocr Connect"},{"issue":"6","key":"8436_CR28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJM199508103330604","volume":"333","author":"E Widen","year":"1995","unstructured":"Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 1995;333(6):348\u201351.","journal-title":"N Engl J Med"},{"issue":"8","key":"8436_CR29","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/humrep\/des191","volume":"27","author":"J Zhang","year":"2012","unstructured":"Zhang J, Fan P, Liu H, Bai H, Wang Y, Zhang F. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS. Hum Reprod. 2012;27(8):2484\u201393.","journal-title":"Hum Reprod"},{"key":"8436_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preghy.2020.02.005","volume":"20","author":"M Zhou","year":"2020","unstructured":"Zhou M, Chen M, Bai H, He GL, Liu QQ, Guan LB, et al. Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women. Pregnancy Hypertens. 2020;20:19\u201326.","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"8436_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/cen.13171","volume":"86","author":"R Zhang","year":"2017","unstructured":"Zhang R, Liu H, Bai H, Zhang Y, Liu Q, Guan L, et al. Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2017;86(1):88\u201396.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"8436_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41390-020-1023-2","volume":"89","author":"M Zhou","year":"2021","unstructured":"Zhou M, Liu XH, Liu QQ, Chen M, Bai H, Jiang CY, et al. Lactonase activity and status of paraoxonase 1 and oxidative stress in neonates of women with gestational diabetes mellitus. Pediatr Res. 2021;89(5):1192\u20139.","journal-title":"Pediatr Res"},{"issue":"6","key":"8436_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/CRD.0b013e31829cabff","volume":"21","author":"RA Mund","year":"2013","unstructured":"Mund RA, Frishman WH. Brown adipose tissue thermogenesis: beta3-adrenoreceptors as a potential target for the treatment of obesity in humans. Cardiol Rev. 2013;21(6):265\u20139.","journal-title":"Cardiol Rev"},{"issue":"2","key":"8436_CR34","doi-asserted-by":"publisher","first-page":"e153357","DOI":"10.1172\/JCI153357","volume":"132","author":"JM Valentine","year":"2022","unstructured":"Valentine JM, Ahmadian M, Keinan O, Abu-Odeh M, Zhao P, Zhou X, et al. beta3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity. J Clin Invest. 2022;132(2):e153357.","journal-title":"J Clin Invest"},{"issue":"1","key":"8436_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-020-01290-y","volume":"19","author":"Z Luo","year":"2020","unstructured":"Luo Z, Zhang T, Wang S, He Y, Ye Q, Cao W. The Trp64Arg polymorphism in beta3 adrenergic receptor (ADRB3) gene is associated with adipokines and plasma lipids: a systematic review, meta-analysis, and meta-regression. Lipids Health Dis. 2020;19(1):99.","journal-title":"Lipids Health Dis"},{"issue":"20","key":"8436_CR36","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1001\/jama.2009.726","volume":"301","author":"JC Chan","year":"2009","unstructured":"Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129\u201340.","journal-title":"JAMA"},{"key":"8436_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00106","volume":"9","author":"YY Li","year":"2018","unstructured":"Li YY, Lu XZ, Wang H, Zhou YH, Yang XX, Geng HY, et al. ADRB3 gene Trp64Arg polymorphism and essential hypertension: a meta-analysis including 9,555 subjects. Front Genet. 2018;9:106.","journal-title":"Front Genet"},{"issue":"8","key":"8436_CR38","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/ijo.2008.90","volume":"32","author":"N Kurokawa","year":"2008","unstructured":"Kurokawa N, Young EH, Oka Y, Satoh H, Wareham NJ, Sandhu MS, et al. The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int J Obes (Lond). 2008;32(8):1240\u20139.","journal-title":"Int J Obes (Lond)"},{"key":"8436_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/973561","volume":"2012","author":"S Takeuchi","year":"2012","unstructured":"Takeuchi S, Katoh T, Yamauchi T, Kuroda Y. ADRB3 polymorphism associated with BMI gain in Japanese men. Exp Diabetes Res. 2012;2012:973561.","journal-title":"Exp Diabetes Res"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08436-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08436-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08436-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:54:17Z","timestamp":1763740457000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-08436-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8436"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08436-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the West China Second Hospital of Sichuan University (Xinghui Liu, No. 2017-033 and Ping Fan, No. 2020-036) and performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1254"}}